Rare diseases
Investigational molecules
Locations
Back to Spain30 clinical trials in Granollers, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
SpainA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
SpainStudy of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)
SpainStudy to evaluate the safety and effectiveness of inhaled nintedanib in patients with idiopathic pulmonary fibrosis
SpainA study testing dust mite allergy extracts from Dermatophagoides pteronyssinus and Dermatophagoides farinae for patients with allergic rhinoconjunctivitis with or without controlled asthma
SpainStudy of abrocitinib oral suspension for children aged 2 years and older with moderate to severe atopic dermatitis to evaluate long-term safety and effectiveness
SpainEffectiveness and Safety of Abrocitinib in Children 6 to Under 12 Years with Moderate-to-Severe Atopic Dermatitis
SpainStudy on Esketamine and Aripiprazole with Antidepressants for Treatment-Resistant Depression in Elderly Patients
SpainStudy on the Effectiveness and Safety of Beltavac for Patients with Allergic Rhinitis from House Dust Mites
SpainStudy on Salbutamol and Ipratropium Bromide for Treating Moderate Asthma Attacks in Children
SpainEfficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis
SpainStudy of IMG-007 injection to treat moderate to severe atopic dermatitis in adults
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical studies focusing on Hidradenitis Suppurativa and Atopic Dermatitis, evaluating new therapeutic approaches including upadacitinib, spesolimab, and lebrikizumab treatments for moderate to severe cases.
Multiple trials are exploring long-term treatment efficacy and safety profiles for persistent skin conditions.
Groundbreaking research in gastrointestinal cancer and bladder cancer treatments, including innovative surgical techniques and immunotherapy approaches using sasanlimab in combination with BCG.
Advanced studies focusing on improving surgical outcomes and developing targeted therapies for various cancer types.
Research initiatives examining Cutaneous Lupus Erythematosus treatments and innovative approaches to allergic rhinoconjunctivitis, including subcutaneous immunotherapy solutions.
Trials are evaluating novel therapeutic compounds and their effectiveness in managing chronic immune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
